Clinical Trials Browser

Phase 3 × Active not recruiting × tislelizumab × Clear all

NCT03967977 2026-04-17

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Phase 3 Active not recruiting

420 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT05152147 2026-04-17

HERIZON-GEA-01

Phase 3 Active not recruiting

920 enrolled

Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Neoplasms, Stomach Neoplasms

NCT04164199 2026-04-14

Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies

Phase 3 Active not recruiting

404 enrolled

Advanced Malignancies

NCT04379635 2026-03-18

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Active not recruiting

453 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04170283 2025-10-21

Long-term Extension Study of Zanubrutinib (BGB-3111) Regimens in Participants With B-cell Malignancies

Phase 3 Active not recruiting

955 enrolled

Lymphoid

B-cell Malignancies

NCT06939439 2025-07-01

Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer

Phase 3 Active not recruiting

416 enrolled

Gastrointestinal

Stomach Neoplasms

NCT04746924 2025-06-24

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Phase 3 Active not recruiting

662 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT05840016 2025-05-02

AK112 in Combination With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Phase 3 Active not recruiting

532 enrolled

Thoracic

Advanced Squamous Non Small Cell Lung Cancer

NCT05211232 2024-04-18

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Phase 3 Active not recruiting

450 enrolled

Head & Neck

Nasopharyngeal Carcinoma